Cargando…

Sublobectomy is a safe alternative for localized cavitary pulmonary tuberculosis

OBJECTIVE: Surgical resection plays an essential role in the treatment of Pulmonary Tuberculosis (PTB). There are few reports comparing lobectomy and sublobectomy for pulmonary TB with cavity. To compare the advantages between lobectomy and sublobectomy for localized cavitory PTB, we performed a sin...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Yong, Zhang, Shaojun, Dong, Zhengwei, Xu, Yong, Hu, Xuefei, Jiang, Gening, Fan, Lin, Duan, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968317/
https://www.ncbi.nlm.nih.gov/pubmed/33731162
http://dx.doi.org/10.1186/s13019-021-01401-5
_version_ 1783666039980032000
author Yang, Yong
Zhang, Shaojun
Dong, Zhengwei
Xu, Yong
Hu, Xuefei
Jiang, Gening
Fan, Lin
Duan, Liang
author_facet Yang, Yong
Zhang, Shaojun
Dong, Zhengwei
Xu, Yong
Hu, Xuefei
Jiang, Gening
Fan, Lin
Duan, Liang
author_sort Yang, Yong
collection PubMed
description OBJECTIVE: Surgical resection plays an essential role in the treatment of Pulmonary Tuberculosis (PTB). There are few reports comparing lobectomy and sublobectomy for pulmonary TB with cavity. To compare the advantages between lobectomy and sublobectomy for localized cavitory PTB, we performed a single-institution cross sectional cohort study of the surgical patients. METHODS: We consecutively included 203 patients undergoing lobectomy or sublobectomy surgery for localized cavitary PTB. All patients were followed up, recorded and compared their surgical complication, outcome and associated characteristics. RESULTS: Both groups had similar outcomes after follow up for 13.1 ± 12.1 months, however, sublobectomy group suffered fewer intraoperative blood losses, shorter length of stay, and fewer operative complications than lobectomy group (P <  0.05). Both groups obtained satisfactory outcome with postoperatively medicated for similar period of time and few relapse (P > 0.05). CONCLUSION: Both sublobectomy and lobectomy resection were effective ways for cavitary PTB with surgical indications. If adequate anti-TB chemotherapy had been guaranteed, sublobectomy is able to be recommended due to more lung parenchyma retain, faster recover, and fewer postoperative complications.
format Online
Article
Text
id pubmed-7968317
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-79683172021-03-19 Sublobectomy is a safe alternative for localized cavitary pulmonary tuberculosis Yang, Yong Zhang, Shaojun Dong, Zhengwei Xu, Yong Hu, Xuefei Jiang, Gening Fan, Lin Duan, Liang J Cardiothorac Surg Research Article OBJECTIVE: Surgical resection plays an essential role in the treatment of Pulmonary Tuberculosis (PTB). There are few reports comparing lobectomy and sublobectomy for pulmonary TB with cavity. To compare the advantages between lobectomy and sublobectomy for localized cavitory PTB, we performed a single-institution cross sectional cohort study of the surgical patients. METHODS: We consecutively included 203 patients undergoing lobectomy or sublobectomy surgery for localized cavitary PTB. All patients were followed up, recorded and compared their surgical complication, outcome and associated characteristics. RESULTS: Both groups had similar outcomes after follow up for 13.1 ± 12.1 months, however, sublobectomy group suffered fewer intraoperative blood losses, shorter length of stay, and fewer operative complications than lobectomy group (P <  0.05). Both groups obtained satisfactory outcome with postoperatively medicated for similar period of time and few relapse (P > 0.05). CONCLUSION: Both sublobectomy and lobectomy resection were effective ways for cavitary PTB with surgical indications. If adequate anti-TB chemotherapy had been guaranteed, sublobectomy is able to be recommended due to more lung parenchyma retain, faster recover, and fewer postoperative complications. BioMed Central 2021-03-17 /pmc/articles/PMC7968317/ /pubmed/33731162 http://dx.doi.org/10.1186/s13019-021-01401-5 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Yang, Yong
Zhang, Shaojun
Dong, Zhengwei
Xu, Yong
Hu, Xuefei
Jiang, Gening
Fan, Lin
Duan, Liang
Sublobectomy is a safe alternative for localized cavitary pulmonary tuberculosis
title Sublobectomy is a safe alternative for localized cavitary pulmonary tuberculosis
title_full Sublobectomy is a safe alternative for localized cavitary pulmonary tuberculosis
title_fullStr Sublobectomy is a safe alternative for localized cavitary pulmonary tuberculosis
title_full_unstemmed Sublobectomy is a safe alternative for localized cavitary pulmonary tuberculosis
title_short Sublobectomy is a safe alternative for localized cavitary pulmonary tuberculosis
title_sort sublobectomy is a safe alternative for localized cavitary pulmonary tuberculosis
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7968317/
https://www.ncbi.nlm.nih.gov/pubmed/33731162
http://dx.doi.org/10.1186/s13019-021-01401-5
work_keys_str_mv AT yangyong sublobectomyisasafealternativeforlocalizedcavitarypulmonarytuberculosis
AT zhangshaojun sublobectomyisasafealternativeforlocalizedcavitarypulmonarytuberculosis
AT dongzhengwei sublobectomyisasafealternativeforlocalizedcavitarypulmonarytuberculosis
AT xuyong sublobectomyisasafealternativeforlocalizedcavitarypulmonarytuberculosis
AT huxuefei sublobectomyisasafealternativeforlocalizedcavitarypulmonarytuberculosis
AT jianggening sublobectomyisasafealternativeforlocalizedcavitarypulmonarytuberculosis
AT fanlin sublobectomyisasafealternativeforlocalizedcavitarypulmonarytuberculosis
AT duanliang sublobectomyisasafealternativeforlocalizedcavitarypulmonarytuberculosis